Human Albumin Market

By Product;

Human Serum Albumin, Recombinant Albumin, and Bovine Serum Albumin

By Type;

5% Concentrations, 25% Concentrations, and Others

By Application;

Therapeutics, Drug Formulation & Vaccine, Component of Media, and Others

By End-user;

Hospitals & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn994446785 Published Date: August, 2025 Updated Date: September, 2025

Human Albumin Market Overview

Human Albumin Market (USD Million)

Human Albumin Market was valued at USD 10,368.64 million in the year 2024. The size of this market is expected to increase to USD 19,322.48 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 9.3%.


Human Albumin Market

*Market size in USD million

CAGR 9.3 %


Study Period2025 - 2031
Base Year2024
CAGR (%)9.3 %
Market Size (2024)USD 10,368.64 Million
Market Size (2031)USD 19,322.48 Million
Market ConcentrationMedium
Report Pages391
10,368.64
2024
19,322.48
2031

Major Players

  • CSL Behring
  • Grifols
  • Baxalta
  • Octapharma
  • Kedrion

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Human Albumin Market

Fragmented - Highly competitive market without dominant players


The Human Albumin Market represents a vital segment of the healthcare industry, offering essential support in critical treatments such as fluid restoration, liver therapy, and surgical care. As an irreplaceable plasma protein, its medical importance has positioned it as a cornerstone of modern clinical practice.

Market Growth
Rising demand has fueled widespread adoption, with more than 52% of applications associated with burns, trauma, and shock management. This reflects its growing role in emergency medicine and its value in stabilizing patients during critical conditions.

Therapeutic Applications
Human albumin contributes significantly to hypoalbuminemia management and surgical recovery, representing nearly 60% of usage. Its effectiveness in regulating fluid distribution and maintaining circulatory stability underlines its importance across diverse medical procedures.

Adoption in Healthcare
Healthcare facilities are increasingly incorporating human albumin, with around 65% of intensive care units using it in advanced treatments. Its proven effectiveness in improving outcomes has reinforced its role as a preferred therapy in acute medical settings.

Future Outlook
The Human Albumin Market is expected to grow further as over 57% of producers invest in innovation, focusing on improved formulations and enhanced supply networks. These developments position human albumin as a key therapeutic solution with long-term relevance in healthcare.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Type
    3. Market Snapshot, By Application
    4. Market Snapshot, By End-user
    5. Market Snapshot, By Region
  4. Human Albumin Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Chronic Diseases

        2. High Adoption Rates in Developed Markets

        3. Rising Demand from the Biotechnology Sector

      2. Restraints
        1. High Cost of Production
        2. Risk of Transmission of Bloodborne Pathogens
      3. Opportunities
        1. Increased Demand in Biotechnology and Vaccine Development

        2. Increased Awareness and Diagnostic Rates

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Human Albumin Market, By Product, 2021 - 2031 (USD Million)

      1. Human Serum Albumin

      2. Recombinant Albumin

      3. Bovine Serum Albumin

    2. Human Albumin Market, By Type, 2021 - 2031 (USD Million)

      1. 5% Concentrations

      2. 25% Concentrations

      3. Others

    3. Human Albumin Market, By Application, 2021 - 2031 (USD Million)
      1. Therapeutics
      2. Drug Formulation & Vaccine
      3. Component of Media
      4. Others
    4. Human Albumin Market, By End-user, 2021 - 2031 (USD Million)

      1. Hospitals & Clinics

      2. Pharmaceutical & Biotechnology Industry

      3. Research Institutes

    5. Human Albumin Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. CSL Behring

      2. Grifols

      3. Baxalta

      4. Octapharma

      5. Kedrion

  7. Analyst Views
  8. Future Outlook of the Market